Predicted pandemic in December 2019 before COVID spread across the world: Bharat Biotech founder

"I said a pandemic will come because signals are coming. As I said, exactly three months later COVID came into the picture," said the Bharat Biotech founder Krishna Ella.

Published: 17th June 2022 10:58 AM  |   Last Updated: 17th June 2022 10:58 AM   |  A+A-

Krishna Ella ,chairman and managing director, Bharat Biotech International Limited

Krishna Ella ,Chairman and MD, Bharat Biotech International Limited (Photo | Biotech4India Twitter)


PARIS: Covaxin maker Bharat Biotech founder on June 16 said that his company is now able to predict a pandemic based on changes in the virus and related signals.

While speaking at the India pavilion at Vivatech 2022, Bharat Biotech founder and chairman Krishna Ella said that the company had predicted the Zika virus around two years before it was noticed and he had also predicted a pandemic in December 2019 before COVID-19 surfaced across the world.

"Zika, we were the first one to file a global patent. Even Atlanta was not aware of Zika. We were the first one in the world. This means we are able to predict the pandemic." Ella said.

He continued, "I said a pandemic will come because signals are coming. As I said, exactly three months later COVID came into the picture. As scientists, we are able to look into how a virus is emerging, re-emerging and how it travels and can spread the disease." 

"Bharat Biotech started in 1997 as a start-up and his old team helped the company make Covaxin and no new talent was engaged in this;" Elle said. 

ALSO READ | ‘Covaxin booster improves efficacy against two variants,’ says Bharat Biotech

Bharat Biotech head said that India has the largest BSL-3 (Bio Safety Level 3) laboratory facility in the world that is used to study infectious agents that can be transmitted through the air and are potentially lethal. "I think we will lead the globe in terms of containment facilities," Ella said.

He said that a lot of machines required for the labs were imported from US and Europe where Indian startups need to come in and start developing equipment required for biotechnology.

Bharat Biotech's chairman said that the government should give incentives to potential investors in startups to support their research and innovation.

"I am for giving some tax incentives to potential investors, private equities, which are funding support areas of the startups in the country. They should be given exemption. Then automatically too much money will flow into startups," Ella said.

He added that a 150 per cent tax deduction on research and development expenses is also no longer available in India and called for continuing such exemption further with a higher level of exemption.


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp